Adam Harkiewicz
Physician Assistant · Henderson, NVNPI 1346585866
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (55.8%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. Mindera Corp accounts for 61.9% of it on its own, with 25 other manufacturers making up the rest. Reporting peaked in 2022 at $15,185 and has fallen 85.7% since, to $2,170 in 2025. Among physician assistant clinicians in NV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 526 payments — averaging $47.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mindera Corp$16K
- AbbVie$2K
- LEO Pharma Inc.$1K
- Johnson & Johnson$976
- Amgen$793
- Sun Pharmaceutical Industries Inc.$741
- plus $4K from 20 others
What the payments were for
- Consulting fees$14,00056%
- Speaking & faculty fees$2,0008%
- Food & beverage$8,66535%
- Education$4372%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mindera Corp | 6 | $15,550 |
| AbbVie | 130 | $2,132 |
| LEO Pharma Inc. | 44 | $1,180 |
| Johnson & Johnson | 44 | $976 |
| Amgen | 45 | $793 |
| Sun Pharmaceutical Industries Inc. | 35 | $741 |
| Dermavant Sciences, Inc. | 55 | $732 |
| Pfizer | 27 | $502 |
| Incyte Corporation | 22 | $406 |
| Lilly USA, LLC | 11 | $301 |
| Organon | 19 | $286 |
| Arcutis Biotherapeutics, Inc. | 21 | $283 |
| Galderma Laboratories, L.p. | 15 | $239 |
| Sanofi | 19 | $233 |
| Regeneron Healthcare Solutions, Inc. | 6 | $176 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 6 | $101 |
| Almirall LLC | 4 | $80 |
| E.r. Squibb & Sons, L.L.C. | 4 | $70 |
| VYNE Pharmaceuticals Inc. | 1 | $65 |
| Botanix SB Inc | 3 | $58 |
| Novartis | 2 | $48 |
| Boehringer Ingelheim | 2 | $40 |
| Bioventus LLC | 1 | $34 |
| Journey Medical Corporation | 2 | $29 |
| UCB, Inc. | 1 | $27 |
| Revance Therapeutics, Inc. | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ADBRY$450
How this compares
$25,103 in reported general payments places this provider in the 95th percentile of 881 physician assistant providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 30 | $112,932 |
| AdbryTralokinumab-Ldrm | 22 | $83,049 |
| OtezlaApremilast | 14 | $63,425 |
| VtamaTapinarof | 12 | $16,781 |
| Clobetasol Propionate | 81 | $3,606 |
| Triamcinolone Acetonide | 156 | $1,731 |
| Ketoconazole | 99 | $1,499 |
| Ciclopirox | 46 | $1,457 |
| Tacrolimus | 11 | $704 |
| Metronidazole | 18 | $684 |
| Doxycycline Hyclate | 41 | $654 |
| Betamethasone Dipropionate | 14 | $603 |
| Fluorouracil | 12 | $586 |
| Mupirocin | 55 | $364 |
| Clindamycin Phosphate | 27 | $360 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| LEO Pharma Inc.Adbry | $1,180 | $83,04922 claims |
| AmgenOtezla | $793 | $63,42514 claims |
| Dermavant Sciences, Inc.Vtama | $732 | $16,78112 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 881 physician assistant providers in Nevada.
Other physician assistant in Henderson
- Anna LiangHenderson$12K
- Jordan DanielsHenderson$12K
- Andrea AlessiHenderson$12K
- Rachel TennisHenderson$12K
- Kelsey MoaklerHenderson$10K
- Laurie MichlinHenderson$8K
- Kevin SnoddyHenderson$8K
- Arial DunsonHenderson$8K
- Logan SussmanHenderson$7K
- Kyle MachyniaStateline$119K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.